<scp>SARS‐CoV</scp>‐2 spike protein found in the acrosyringium and eccrine gland of repetitive miliaria‐like lesions in a woman following <scp>mRNA</scp> vaccination
The Journal of Dermatology
Clinical Summary
View sourceWhat was studied
A report of repetitive miliaria-like skin lesions in a woman after mRNA COVID-19 vaccination, examining whether SARS‑CoV‑2 spike protein was present in the acrosyringium and eccrine gland.
Key findings
SARS‑CoV‑2 spike protein was detected in the acrosyringium and eccrine glands of the miliaria-like lesions.
Study limitations
Single-patient report, limiting generalizability and causal inference.
Related Questions
Explore related topics and deepen your understanding
How should clinicians evaluate miliaria-like eruptions reported after mRNA COVID-19 vaccination?What histopathologic findings, including eccrine involvement, are reported in post-vaccination cutaneous eruptions?What management strategies are described for miliaria-like rashes potentially associated with vaccines?